Pain might be an important risk factor for common mental disorders. Insight into the longitudinal association between pain and common mental disorders in the general adult population could help improve prevention and treatment strategies. Data were used from the first 2 waves of the Netherlands Mental Health Survey and Incidence Study-2, a psychiatric epidemiological cohort study among the Dutch general population aged 18 to 64 years at baseline (N 5 5303). Persons without a mental disorder 12 months before baseline were selected as the at-risk group (n 5 4974 for any mood disorder; n 5 4979 for any anxiety disorder; and n 5 5073 for any substance use disorder). Pain severity and interference due to pain in the past month were measured at baseline using the Short Form Health Survey. DSM-IV mental disorders were assessed at both waves using the Composite International Diagnostic Interview version 3.0. Moderate to very severe pain was associated with a higher risk of mood (odds ratio [OR] 5 2.10, 95% confidence interval [CI] 5 1.33-3.29) or anxiety disorders (OR 5 2.12, 95% CI 5 1.27-3.55). Moderate to very severe interference due to pain was also associated with a higher risk of mood (OR 5 2.14, 95% CI 5 1.30-3.54) or anxiety disorders (OR 5 1.92, 95% CI 5 1.05-3.52). Pain was not significantly associated with substance use disorders. No interaction effects were found between pain severity or interference due to pain and a previous history of mental disorders. Moderate to severe pain and interference due to pain are strong risk factors for first-incident or recurrent mood and anxiety disorders, independent of other mental disorders. Pain management programs could therefore possibly also serve as a preventative program for mental disorders.
Introduction
According to the International Association for the Study of Pain (IASP), pain is "an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage." 6 Nineteen percent of the adult European population suffers from moderate to severe pain. 7 Pain has substantial impact on quality of life and mental health. Thorough research exists examining the prevalence and cross-sectional association between pain and common mental disorders in population-based 3, 23 and clinical studies. 2, 11, 21, 24, 25 The economic and societal burden of pain and common mental disorders is high, 2, 17, 21, 29 and therefore composes a relevant public health problem. A better understanding of the prospective contribution of pain in mental disorders might be instrumental in identifying better strategies for prevention and early interventions of mental disorders, particularly because pain is modifiable. However, results of longitudinal studies, assessing the effect of pain on firstincident and recurrent mental disorders, are scarce.
In studies from clinical settings, 10,13,14 a longitudinal association between pain and mental disorders was found. Among atrisk stimulant (cocaine and methamphetamine) users, subjects with a higher number of days with pain (which interfered with work and social activities) were more likely to develop alcohol and opioid abuse/dependence compared with subjects without pain. 10 In 2 studies from the Netherlands Study of Depression and Anxiety (NESDA)-1 among subjects with no previous history of and no current depressive or anxiety disorder, 13 and 1 among subjects with a remitted depressive or anxiety disorder 14 -a higher number of pain locations and more severe pain were associated with the onset of a depressive and anxiety disorder, and with the recurrence of a depressive disorder. However, the extent to which results from these clinical studies can be generalized to the general population is unknown, and these results therefore need to be replicated and validated in population-based studies.
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Several population-based studies have investigated such a longitudinal association between pain and symptoms of depression 1, 12, 19 and of anxiety. 1, 12 In nondepressed subjects, those with moderate to severe interference due to pain, 1 more severe pain, 19 and chronic low back pain 12 were more likely to report depressive symptoms at follow-up, compared with those without pain. In nonanxious subjects, the same results were found for moderate to severe interference due to pain 1 and chronic low back pain. 12 After adjusting for affective disorder at baseline, the strength of the pain-affect associations was weakened, 1 suggesting that they modify each other's association with pain. However, the results of these studies are limited because they focus on an elderly population, 1, 19 and relied on self-report questionnaires to measure symptoms of mental health problems in the last week 1, 12, 19 rather than on standardized diagnostic interviews to assess current and history of mental disorders. Furthermore, these studies focus either on depression and anxiety or on substance use disorders only, but as these are among the most common mental disorders in adults, 29 they should be studied in concert. This study aims to address these gaps.
Methods

Setting and participants
In short, the Netherlands Mental Health Survey and Incidence Study-2 (NEMESIS-2) has a longitudinal epidemiological cohort design. This study was conducted among the Dutch general population aged 18 to 64 years. It is based on a multistage, stratified random sampling of households, with 1 respondent randomly selected in each household. In the first wave (T0), performed from November 2007 to July 2009, a total of 6646 persons were interviewed (response rate 65.1%; average interview duration 95 minutes). This sample was nationally representative, although younger subjects were somewhat underrepresented. 5 All T0 respondents were approached for followup (T1) 3 years after T0, from November 2010 to June 2012. Of this group, 5303 persons were reinterviewed (response rate 80.4%, excluding those deceased; average interview duration 84 minutes). Attrition rate was not significantly associated with all main categories of mental disorders (ie, mood, anxiety, and substance use) and all individual 12-month mental disorders at baseline, after controlling for sociodemographic characteristics. 16 Comprehensive data on attrition in NEMESIS-2 can be found elsewhere. 16 More severe pain was, however, significantly associated with less attrition (odds ratio [OR] 5 0.91; P 5 0.01), after adjustment for sociodemographic characteristics. The interviews were laptop computer assisted and almost all were held at the respondent's home. The mean period between both interviews was 3 years and 7 days. The Medical Ethics Committee for Institutions on Mental Health Care (METIGG) approved the study. After having been informed about the study objective, respondents provided written informed consent. A more comprehensive description of the design is provided elsewhere. 15 For this study, 3 different at-risk groups were selected: (1) subjects without any 12-month mood disorder at baseline (n 5 4974); (2) subjects without any 12-month anxiety disorder at baseline (n 5 4979); and (3) subjects without any 12-month substance use disorder at baseline (n 5 5073). For subjects in each of these at-risk groups, it was possible to have another mental disorder at baseline. For example, those at-risk for incident or recurrent mood disorders at follow-up, thus those not having a mood disorder 12 months before baseline, could have an anxiety or substance use disorder 12 months before baseline. As a mental disorder before 12 months prior to baseline was not an exclusion criterion, a disorder at follow-up could be either a first-incident case or a recurrent case. Data were used from the first 2 waves of NEMESIS-2.
Variables
Dependent variables: mental disorders
Mental disorders were assessed using the Composite International Diagnostic Interview (CIDI) version 3.0, a fully structured layadministered diagnostic interview of mental disorders. 22 The CIDI was developed and adapted for use in the World Mental Health Survey Initiative. In the Netherlands, the CIDI 3.0 was first used in ESEMeD, which is part of this initiative. 4 The CIDI 3.0 version used in NEMESIS-2 was an improvement of the one used in the Dutch ESEMeD study (some small improvements were administered, such as reformulation of questions to better match the English version). The mental disorders considered in this article include any mood disorder (major depression, dysthymia, and bipolar disorder), any anxiety disorder (panic disorder, agoraphobia, social anxiety disorder, and generalised anxiety disorder), and any substance use disorder (alcohol/drug abuse and dependence). Research has demonstrated acceptable reliability and validity for assessing these common mental disorders. 18 The appearance of any common mental disorder (ie, any mood, anxiety, or substance use disorder) between baseline and followup was the outcome variable of this study.
At baseline, respondents were asked whether a mental disorder lifetime occurred to them and, if so, if this happened in the past 12 months. At T1, respondents were asked the same questions about mental disorders, but then the period referred to mental disorders that they had experienced since the baseline interview.
Predictor: pain assessments
At baseline, pain severity was assessed using a question from the SF-36-item Short Form Health Survey 28 : "How much pain did you experience in the past 4 weeks?" Respondents could choose between "no pain," "very little pain," "little pain," "moderate pain," "severe pain," and "very severe pain." These answers were categorised into: 0 5 no pain, 1 5 very little pain, 2 5 little pain, and 3 5 moderate to very severe pain.
Interference due to pain was measured with the SF-36 question: "How much interference did you experience with normal activities (including work outside household, and domestic work) in the past 4 weeks as a consequence of pain?". Respondents could choose between "no interference," "little interference," "moderate interference," "much interference," and "very much interference." These answers were categorised into: 0 5 no interference, 1 5 little interference, and 2 5 moderate to very much interference. The pain scale of the SF-36, consisting of pain severity and interference due to pain, has a high reliability. 26 
Covariates
The demographics at baseline were as follows: age in categories (18-24, 25-34, 35-44, 45-54, and 551), sex, education (primary, lower secondary, higher secondary, and higher professional/ university), living situation (with partner or not), and working situation (having a paid job or not). Furthermore, mental disorders reported at baseline, other than the dependent variable, were selected as covariates. For example, in the analyses for mood disorder, in which subjects with a mood disorder 12 months before baseline were excluded, 12-month anxiety disorder and 12-month substance use disorder at baseline were selected as covariates.
Statistical methods
First, cross-sectional analyses were performed to examine baseline differences regarding sociodemographic characteristics and mental disorders for pain severity and interference due to pain, for all the 5303 subjects. Second, logistic regression analyses were performed, for each mental disorder separately, to examine the risks of both pain severity and pain interference on first incidence or recurrence of the mental disorder 3 years later. In all analyses, we first adjusted for demographics and the time between measurements (model 1) and additionally for other psychopathology at baseline (model 2). For example, in the fully adjusted model to study risk indicators of any incident or recurrent mood disorder (model 2), 12-month anxiety and substance use disorder at baseline were included as covariates. Persons with no pain and persons with no interference due to pain were selected as the reference category. To test for linear trends, potential determinants (ie, pain severity and interference due to pain) were also modelled separately as continuous variables (P for trend test). Moreover, we studied whether a previous history of a mental disorder modified the association between pain and the risk of a mental disorder at 3-year follow-up. Six interaction effects were calculated between a previous history of a mental disorder and the 2 types of pain (severity and interference) on incident or recurrent disorders at follow-up (ie, mood, anxiety, and substance use disorders). Two-tailed testing procedures were used in all analyses with 0.05 alpha levels, except the interaction analyses, where an alpha of 0.001 was used. All statistical analyses were performed with Stata version 12.1, using weighted data to ensure that they were representative of the national population. Robust standard errors were calculated to obtain correct 95% confidence intervals (CIs) and P values.
Results
Descriptive data
The baseline characteristics of all 5303 respondents who participated at the first 2 waves, tabulated according to the presence of the 2 pain characteristics (severity and interference) are shown in Table 1 .
Being female, less educated, not having a paid job, and presence of any mood, anxiety, and substance use disorder 12 months before baseline were significantly associated with a higher score on pain severity. Female sex, older age, lower education, not having a paid job, presence of any mood, and anxiety disorder 12 months before baseline were significantly associated with a higher score on interference due to pain.
Outcome data and main results
Of the 4974 persons at risk of a mood disorder, 304 developed a mood disorder (185 a first-incident disorder and 119 a recurrent disorder) over the next 3 years. Of the 4979 persons at risk of an anxiety disorder, 179 developed an anxiety disorder (131 a firstincident disorder and 48 a recurrent disorder) over the next 3 years. Of the 5073 persons at risk of a substance use disorder, 160 developed a substance use disorder (100 a first-incident disorder and 60 a recurrent disorder) over the next 3 years. Thus, most cases developed a first-incident disorder. Table 2 shows the ORs for first-incidence or recurrence of any mood disorder, any anxiety disorder, and any substance use disorder 3 years later by pain severity and interference due to pain at baseline.
Respondents with little pain severity at baseline (n 5 784, 14.0%) had more than 2 times higher odds of developing any anxiety disorder 3 years later (OR 5 2.33; 95% CI 5 1.41-3.85), compared with those without pain. Respondents with moderate to very severe pain at baseline (n 5 797, 15.1%) had 2 times higher odds of developing any mood disorder (OR 5
those without pain. Respondents with moderate to very severe interference due to pain at baseline (n 5 451, 8.3%) also had approximately 2 times higher odds of developing any mood disorder (OR 5 2.14; 95% CI 5 1.30-3.54) and any anxiety disorder (OR 5 1.92; 95% CI 5 1.05-3.52) 3 years later, compared with those without interference due to pain. Compared with model 1, adjusting for other psychopathology at baseline (model 2) slightly reduced the effect of baseline interference due to pain. Both pain characteristics (severity and interference) at baseline were not significantly associated with any incident or recurrent substance use disorder at follow-up. The P for trend analyses showed that with higher pain severity and with more interference due to pain, the risk of any incident or recurrent mood and anxiety disorder increased (all models: P , 0.01). This did not apply for any incident substance use disorders.
No interaction effects were found for a previous history of a mood disorder with pain on the risk of developing a mood disorder at 3-year follow-up, a previous history of an anxiety disorder with pain on the risk of developing an anxiety disorder at 3-year follow-up, and a previous history of a substance use disorder with pain on the risk of developing a substance use disorder at 3-year follow-up. These effects applied for both pain severity and interference due to pain. This implies that the association between pain and mental disorders did not significantly differ between subjects with a first onset and subjects with a recurrent mental disorder.
Discussion
This is one of the first large scale studies assessing pain as a risk factor for the prospective development of first or recurrent episodes of common mental disorders in the adult general population. Prevalence of moderate to very severe pain was 15.1% and for moderate to very severe interference due to pain 8.3%. These subjects had a more that twofold increased risk of developing a first-incident or recurrent mood and anxiety disorder 3 years later. Adjusting for mental disorder at baseline, other than the one as the dependent variable, only slightly attenuated the strength of the pain-mental disorder associations. Moreover, the effect of pain on mental disorders did not differ between subjects who developed a first-incident mental disorder and subjects who developed a recurrent mental disorder. Our findings, therefore, show that pain is a common, strong, and unique risk factor for mood and anxiety disorders.
Our findings are consistent with and extend previous longitudinal findings between pain and mood and anxiety. 1, 13, 14, 19 The strength of the association between pain severity and interference due to pain with mood and anxiety disorders is higher in the current study compared with previous longitudinal studies: In clinical studies, more severe pain increased the risk of onset of a depressive and anxiety disorder between a 1-and 2-fold factor 13 and for recurrence of depression by a 1.2-fold factor 14 ; in population studies, among elderly, more severe pain increased the risk of depressive symptoms by a 1.1-fold factor, 19 and more interference due to pain increased the risk of depressive and anxiety symptoms by almost a 2-fold factor. 1 In this study, a more than 2-fold increased risk was found for both pain severity and interference due to pain in developing a mood and anxiety disorder. This may be attributed to methodological differences in study sample, study size, and outcome measures. For example, although the population studies 1, 19 used nondepressed and nonanxious subjects, depression and anxiety were measured with a self-report questionnaire regarding symptoms in the last week. A major contribution of this study is the use of a standardized diagnostic interview to assess mental disorders in the past 12 months and lifetime history of mental disorders. This enabled us to (1) assess clinical and chronic symptoms of common mental disorders, (2) assess the risk of pain in subjects without a mental disorder Sociodemographics and mental disorders of all respondents who participated at the first 2 waves across pain characteristics in the general population, in unweighted numbers and weighted column percentages at baseline (N 5 5303). in the past 12 months, and (3) evaluate whether the risk of pain differs in subjects with a recurrent mental disorder and subjects with a first-onset mental disorder. Our findings, therefore, extend previous literature by showing that when pain becomes more severe or interferes with normal activities, the risk of full-blown first-incident or recurrent mood and anxiety disorders increases substantially in the general adult population.
Regarding first-incident and recurrence of substance use disorder, we found no association with pain severity or with interference due to pain at baseline. In a study among at-risk stimulant users, more days of pain (which interfered with work and social activities) was associated with a 2-to 3-fold increase of developing a substance use disorder. 10 It could therefore be expected that, in this study, interference due to pain would also be associated with substance use disorder. A possible explanation for this discrepancy might be attributed to several methodological differences. Edlund et al. 10 used a sample of at-risk stimulant users, which might not be comparable with the general adult population. Furthermore, they used a nonvalidated measure for pain and adjusted their results only for severity of depression, based on a short selfreport questionnaire. However, it could also indicate that pain is a risk factor for developing a substance use disorder in an atrisk sample, but not in the general adult population. Nevertheless, Volkow et al. 27 warn for the possible abuse hazards of opioid use by patients with chronic pain, as opioid analgesics are the most commonly prescribed class of medications for pain, with an elevated risk of abuse and addiction. In our study, we were unable to distinguish between specific substance use disorders, such as opioid use, because of a small number of subjects in this category. Therefore, in future studies, the specific association between pain, mental disorders, and opioid use should be taken into account.
Strengths and limitations
This study had the advantage of a large population sample, which was followed up for 3 years, the use of a standardized instrument to assess common mental disorders and the possibility to adjust for a wide variety of confounders in investigating the relationship between pain characteristics at baseline and mental disorders at follow-up. However, some limitations have to be mentioned.
The outcome of the main analysis was aggregated, as we have pooled both first-incident and recurrent mental disorders. However, we did examine whether results would differ for subjects with a recurrent mental disorder from those with a first-incident mental disorder and found no significant difference. This might be explained because of the relatively small number of subjects with a recurrent or first-incident mental disorder at follow-up, especially for anxiety (48 subjects with a recurrent disorder and 131 subjects with a first-onset disorder) and substance use disorders (60 subjects with a recurrent disorder and 100 subjects with a first-onset disorder). Studies with larger sample sizes of incident and recurrent mental disorders are needed to study this more accurately. Mental disorders were also aggregated by pooling several specific mood, anxiety, and substance use disorders because of the small numbers reporting a specific mental disorder. Consequently, no inferences can be made whether pain is a risk factor in developing one of these specific disorders and in developing another mental disorder not considered in our study. In addition, the use of the SF36 to measure pain severity and interference due to pain is limited. This questionnaire only asks for pain in the past 4 weeks, so no inferences could be made on chronic pain. However, in 2 large clinical studies, chronic pain (pain with a duration of at least 90 days) was not associated more strongly with the onset and recurrence of a depressive and anxiety disorder when compared with less chronic pain, 13, 14 indicating that current severe pain might be a more important risk factor when considering mental disorders. Despite a follow-up period of 3 years in this study, we cannot make any inferences about a causal pathway of pain towards a mental disorder. Besides, it is possible that factors not studied here might play a mediating role in the link between pain and mental disorders. For example, sleep problems can play a mediating role in the link between persistent pain and depression and anxiety. 8, 9 Dysfunctional cognitive pain responses, such as catastrophizing or hopelessness, also seem to mediate the association between pain and depression. 20 In future research and interventions of pain, problems with sleep and dysfunctional cognitive responses should therefore also be considered. Sleep problems and dysfunctional cognitions are modifiable factors, and when these factors mediate the association between pain and mental disorders, interventions targeted at sleep and cognitions might also be effective in reducing both pain and the risk of mental disorders.
Conclusion/clinical implications
Our finding that pain has a significant impact in the development of a mental disorder in the adult general population is important for health professionals, who would do well by monitoring and detecting possible symptoms of a mental disorder when pain symptoms are present. Pain management programs could then possibly also serve as a preventative program for mental disorders in subjects with pain; reducing pain symptoms might lead to a reduced risk of developing a mental disorder. However, more longitudinally research studies are needed exploring causality and other mediating factors in the association between pain and mental disorders.
